Rienmüller R K, Behr J, Kalender W A, Schätzl M, Altmann I, Merin M, Beinert T
Department of Radiology, Klinikum Grosshadern, Ludwig Maximilians University of Munich, F.R.G.
J Comput Assist Tomogr. 1991 Sep-Oct;15(5):742-9. doi: 10.1097/00004728-199109000-00003.
Twenty-seven patients with diffuse fibrosing alveolitis (DFA), 27 patients with granulomatous lung disease (GLD), 3 patients with homozygous alpha 1-proteinase inhibitor deficiency (alpha 1-PID), and 6 healthy volunteers (C) were studied using thin section high resolution CT (HRCT) at 50% of actual vital capacity (VC), determined and controlled spirometrically during each exposure. A fast contour tracing algorithm was used to isolate the lung parenchyma followed by a quantitative histogram analysis of the frequencies of CT values. Mean CT values enabled us to discriminate significantly between the groups of C and alpha 1-PID. Significant differences were found between the groups of GLD and DFA versus C by applying suitably selected intervals of CT values. Moreover, if the patients were assigned to four different groups according to their lung function results (normal, restrictive, obstructive, restrictive and obstructive), again significant differences existed with respect to defined intervals of CT values. Mean CT values showed a significant negative correlation with lung function tests representative of lung parenchymal disease, i.e., VC, diffusing capacity, and exercise PaO2. Moreover, CT values ranging from -899 to -800 HU correlated positively, whereas CT value frequencies above -699 HU correlated inversely with these same lung function parameters. These results indicated that certain intervals of CT values do reflect functionally different abnormalities of lung parenchyma. It is concluded that an analysis of frequencies of CT values determined by spirometrically standardized HRCT provides objective quantitative data that reflect changes of pulmonary structure corresponding to lung function impairments. Thus, spirometrically standardized HRCT may be helpful for evaluating and staging patients with diffuse pulmonary disease.
对27例弥漫性纤维化肺泡炎(DFA)患者、27例肉芽肿性肺病(GLD)患者、3例纯合子α1 -蛋白酶抑制剂缺乏症(α1 - PID)患者和6名健康志愿者(C)进行了研究。使用薄层高分辨率CT(HRCT)在实际肺活量(VC)的50%时进行扫描,每次扫描时通过肺活量测定法确定并控制VC。采用快速轮廓追踪算法分离肺实质,然后对CT值频率进行定量直方图分析。平均CT值使我们能够显著区分C组和α1 - PID组。通过应用适当选择的CT值区间,发现GLD组和DFA组与C组之间存在显著差异。此外,如果根据患者的肺功能结果(正常、限制性、阻塞性、限制性和阻塞性)将患者分为四个不同组,在定义的CT值区间方面再次存在显著差异。平均CT值与代表肺实质疾病的肺功能测试,即VC、弥散能力和运动时的动脉血氧分压呈显著负相关。此外,- 899至- 800 HU的CT值呈正相关,而高于- 699 HU的CT值频率与这些相同的肺功能参数呈负相关。这些结果表明,特定的CT值区间确实反映了肺实质功能上不同的异常。结论是,对通过肺活量测定法标准化的HRCT确定的CT值频率进行分析可提供客观的定量数据,反映与肺功能损害相对应的肺结构变化。因此,肺活量测定法标准化的HRCT可能有助于评估和分期弥漫性肺病患者。